<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="369392">
  <stage>Registered</stage>
  <submitdate>25/09/2015</submitdate>
  <approvaldate>27/11/2015</approvaldate>
  <actrnumber>ACTRN12615001297516</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of  postoperative pain scores with deep versus moderate neuromuscular blockade during laparoscopic cholecystectomy.</studytitle>
    <scientifictitle>In patients undergoing laparoscopic cholecystectomy, what is the effect of deep versus moderate muscle blockade on postoperative pain scores?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>postoperative pain</healthcondition>
    <healthcondition>cholecystitis</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Group 1: Deep neuromuscular blockade with bolus intraveneous 1 mg/kg rocuronium for 8 mmHg intraabdominal pressure for pneumoperitoneum at the beginning of the procedure. 5% carbon dioxide (CO2) at 37 degrees Celsius and 50% humidity was used for pneumoperitoneum from time of incision to time of closure of the abdomen. 0.1-0.2 mg/kg rocuronium was administered multiple doses at clinical discretion of anaesthetist to maintain deep neuromuscular blockade during surgery if post-tetanic count &gt;1. Group 2: moderate neuromuscular blockade with bolus intraveneous 0.5 mg/kg rocuronium for 12 mmHg intraabdominal pressure for pneumoperitoneum at the beginning of the procedure. 5% carbon dioxide (CO2) at 37 degrees Celsius and 50% humidity was used for pneumoperitoneum from time of incision to time of closure of the abdomen. No further rocuronium was administered for moderate blockade.</interventions>
    <comparator>Group 2:Moderate neuromuscular blocade with bolus intraveneous 0,5 mg/kg rocuronium at the beginning of the procedure and no further rocuronium was administered during the surgery.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Effect of the deep and moderate muscle blockade on postoperative pain scores. Assessment was done with 11 point numerical rating scale.</outcome>
      <timepoint>postoperative pain assessment at 1, 2 ,4, 8,12, 18 hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Comparision of the low (8mmHg) and standard(12mmHg) insufflation pressures affect on surgical space conditions during the laparoscopy.</outcome>
      <timepoint>assessment of the surgical area with four point scale and numeric rating scale after initiation and at the end of the surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comparision of the low (8mmHg) and standard(12mmHg) insufflation pressures affect on postoperative pain scores used 11 point numeric rating scale</outcome>
      <timepoint>postoperative pain assessment at 1, 2 ,4, 8,12, 18 hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA(American Society of Anesthesiologists) 1-2 Patients
Undergo laparoscopic cholecystectomy
</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Body Mass Index greater than 35
Body Mass Index less than 18
Neurological Disorders
Coagulopathy
Allergic to narcotic and NSAID agents
Cancer patients
Chronic Pain Disorders</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>1/12/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/05/2015</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>50</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Istanbul</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Istanbul training and research hospital</primarysponsorname>
    <primarysponsoraddress>Abdurrahman nafiz Gurman Street postal code:34098 Fatih /Istanbul</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We assessed the postoperative pain scores with 11 point numeric rating scale for deep and moderate muscle blockade after laparoscopic cholecystectomy. In addition we assessed the surgical space conditions during surgery with 4-point scale and numeric rating scale.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes>ethics approval was not attained prior to recruitment of the first participant. because our ethical comitee did not approved. Then we finished the recruitment, they approved the study so ethical comitee date was late. </publicnotes>
    <ethicscommitee>
      <ethicname>Istanbul training and research hospital</ethicname>
      <ethicaddress>Kasap Ilyas district Org.Abdurrahman Nafiz Gurman street Postal code:34098 FATIH</ethicaddress>
      <ethicapprovaldate>14/08/2015</ethicapprovaldate>
      <hrec>690</hrec>
      <ethicsubmitdate>12/08/2015</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>VEYSEL ERDEN</name>
      <address>Istanbul Research and Education Hospital Kasap Ilyas district Org.Abdurrahman Nafiz Gurman street Postal code:34098 FATIH/ ISTANBUL</address>
      <phone>+90 212 459 60 00</phone>
      <fax />
      <email>v_erden@hotmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>CIHAN GULER</name>
      <address>Istanbul Research and Education Hospital Kasap Ilyas district Org.Abdurrahman Nafiz Gurman street Postal code:34098 FATIH/ ISTANBUL</address>
      <phone>+90 212 459 60 00</phone>
      <fax />
      <email>cianguler@gmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>CIHAN GULER</name>
      <address>Istanbul Research and Education Hospital Kasap Ilyas district Org.Abdurrahman Nafiz Gurman street Postal code:34098 FATIH/ ISTANBUL</address>
      <phone>+90 212 459 60 00</phone>
      <fax />
      <email>cianguler@gmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>CIHAN GULER</name>
      <address>Istanbul Research and Education Hospital Kasap Ilyas district Org.Abdurrahman Nafiz Gurman street Postal code:34098 FATIH/ ISTANBUL</address>
      <phone>+90 212 459 60 00</phone>
      <fax />
      <email>cianguler@gmail.com</email>
      <country>Turkey</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>